These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1293771)
1. [Non-Hodgkin's lymphomas. I. Clinico-biological features of 307 cases]. García Zueco JC; Delgado MP; Giraldo MP; Perella M; Torres M; Valero MI; Ríos MJ; García Julián G; Giralt M Sangre (Barc); 1992 Oct; 37(5):331-6. PubMed ID: 1293771 [TBL] [Abstract][Full Text] [Related]
2. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients]. García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772 [TBL] [Abstract][Full Text] [Related]
3. [Post-therapeutic evolution and prognostic factors of intestinal lymphomas, Retrospective analysis of 42 cases]. Sánchez-Fayos MP; Hernández Guío C; Rivas MC; Outeiriño J; González-Campos C; Lobo F Sangre (Barc); 1993 Dec; 38(6):455-62. PubMed ID: 8171381 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma]. Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in low-grade lymphoma]. Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223 [TBL] [Abstract][Full Text] [Related]
6. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry. Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722 [TBL] [Abstract][Full Text] [Related]
7. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A; Berg R Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605 [TBL] [Abstract][Full Text] [Related]
8. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy]. Bettini R; Caronni F; Maino C; Marzetta K; Sala D; Saccà V; Gorini M Recenti Prog Med; 2003 Nov; 94(11):494-500. PubMed ID: 14679917 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
10. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277 [TBL] [Abstract][Full Text] [Related]
11. Age-related prognostic factor analysis in non-Hodgkin's lymphoma. Maksymiuk AW; Haines C; Tan LK; Skinnider LF Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516 [TBL] [Abstract][Full Text] [Related]
12. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma]. Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071 [TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
14. The National Cancer Data Base report on non-Hodgkin's lymphoma. Glass AG; Karnell LH; Menck HR Cancer; 1997 Dec; 80(12):2311-20. PubMed ID: 9404709 [TBL] [Abstract][Full Text] [Related]
15. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576 [TBL] [Abstract][Full Text] [Related]
17. [Non-Hodgkin's lymphomas associated with the acquired immunodeficiency syndrome. A multicenter clinical study of 77 cases]. Rubio R; Pulido F; Pintado V; Díaz-Mediavilla J; Flores E; Serrano M; Alberdi JC; López-Gay D; Verdejo J; Barros C Med Clin (Barc); 1995 Apr; 104(13):481-6. PubMed ID: 7746011 [TBL] [Abstract][Full Text] [Related]
18. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia]. Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774 [TBL] [Abstract][Full Text] [Related]
19. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience. Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844 [TBL] [Abstract][Full Text] [Related]
20. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group). Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]